The novel fosfomycin resistance gene fosY is present on a genomic island in CC1 methicillin-resistant Staphylococcus aureus

Fosfomycin has gained attention as a combination therapy for methicillin-resistant Staphylococcus aureus infections. Hence, the detection of novel fosfomycin-resistance mechanisms in S. aureus is important. Here, the minimal inhibitory concentrations (MICs) of fosfomycin in CC1 methicillin-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yiyi, Ji, Shujuan, Sun, Lu, Wang, Haiping, Zhu, Feiteng, Chen, Mengzhen, Zhuang, Hemu, Wang, Zhengan, Jiang, Shengnan, Yu, Yunsong, Chen, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Antimicrobial Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037201/
https://www.ncbi.nlm.nih.gov/pubmed/35332834
http://dx.doi.org/10.1080/22221751.2022.2058421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037201/
https://www.ncbi.nlm.nih.gov/pubmed/35332834
http://dx.doi.org/10.1080/22221751.2022.2058421

Ejemplares similares